The Metabolic AI Digital Twin
The true breakthrough relates to the production of the AI digital twin™. By leveraging a network of wearable sensors, such as CGMs and fitness trackers, advanced AI can create an individual’s unique metabolic signature. For those living with Type 2 diabetes, this enables the creation of a personalized health roadmap that identifies a path to remission without the traditional “trial and error” approach to medicine.
Clinical Success and Tangible Results
Explore Tomorrow's World From Your Inbox
Get the latest science, technology, and sustainability content delivered to your inbox.
I understand that by providing my email address, I agree to receive emails from Tomorrow's World Today. I understand that I may opt out of receiving such communications at any time.
The inspiration behind this technology is matched by its documented real-world impact. According to a landmark study published in NEJM Catalyst, the results of this digital transition are significant. A vast majority of participants (71%) achieved Type 2 diabetes remission (A1C < 6.5%) while eliminating almost all medications. Furthermore, nine out of ten patients (90%+) allowed for a significant reduction or stopped using supplemental insulin.
Beyond improved health, the technology ensures future financial sustainability. A recent Twin Health report proves this model is highly efficient. The data indicates an average $9,047 reduction in annual costs per member, driven largely by a $4,690 drop in pharmacy spend as patients no longer require expensive chronic medications.
The Future of Specialized Production
The innovation of metabolic digital twins is only the beginning. This same model is currently being adapted for the production of treatments for hypertension and liver disease. By creating actionable insights from biological data, we are witnessing the innovation of a future in which disease is reversed, not just managed. This represents the ultimate inspiration for a healthier tomorrow.
